Fluidigm Stock a High Flyer in October as Sequenom, PacBio Shares Dropped Sharply | GenomeWeb

NEW YORK (GenomeWeb News) – Shares of Fluidigm rose nearly 44 percent during October, pacing the gainers in the GenomeWeb Daily News Index for the month, while Sequenom saw the biggest month-over-month drop at 28 percent.

Overall, the GWDN Index was up a little more than 3 percent, mostly on par with the broader market. The Dow Jones Industrial Average was up 3 percent in October, while the Nasdaq Composite was up 4 percent. The Nasdaq Biotech Index was down 2 percent in the month, however.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.